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Abstract
Background: The staging of axillary lymph nodes is critical to the management and prognosis of breast cancer, the
most frequent cancer in females. Neoadjuvant therapy and lymph node dissection are recommended when
malignant cells invade the lymph nodes. Therefore the pre-operative examination of these lymph nodes is crucial
to treatment.
Methods: In this study, we examined the effectiveness of cytology through ultrasound-guided fine needle
aspiration (USG-FNA) and ultrasound (US) imaging using an established classification system in correctly identifying
lymph node status compared to the final histological results after surgery.
Results: Cytology by USG-FNA and US classification were found to be promising methods of axillary lymph node
staging.
Conclusions: US and CB offer minimally invasive techniques to pre-operatively examine these lymph nodes in
patients with primary breast cancer.
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Background
Breast cancer is the most frequent female cancer [1] and
the second leading cause of female cancer death in
Belgium [2]. Therefore, breast cancer management is
critically important. When an axillary lymph node is
invaded, neoadjuvant chemotherapy and axillary lymph
node dissection are indicated [3, 4]. In terms of survival,
it is now widely accepted that there are advantages of
neoadjuvant chemotherapy in patients with node-
positive breast cancer [3, 4]. Axillary lymph node status
is an important factor in the prognosis and management
of breast cancer. Several methods to detect positive
axillary lymph nodes during the pre-operative diagnosis
have been evaluated, including ultrasound-guided fine
needle aspiration (USG-FNA) cytology, ultrasound-
guided biopsy and, as an imaging method, axillary ultra-
sound [5]. If a positive lymph node is not found during
the pre-operative evaluation, a less invasive sentinel
node biopsy will be utilized instead of axillary lymph
node dissection [6]. The goal of this study was to
compare the results of axillary lymph node status by
cell-block obtained through fine-needle aspiration [7]
and by axillary ultrasound, according to a classification
system derived from Stavros [8].
Methods
Patient dataset
The Hôpital Erasme ethics committee approved this
study. All the results were analyzed retrospectively
and anonymously.
This study included a series of 208 cell or cyto-
blocks (CB) of axillary or para-axillary (chest wall,
subclavicular and intra-mammary) lymph nodes from
184 patients (141 patients with one, 18 patients with
two, one patient with three, and one patient with four
evaluated lymph nodes) with primary breast cancer
from a university center collected between October
2008 and August 2012.
Fine-needle aspirations were performed on all patients
by a radiologist using a 21-gauge, ultrasonographic (US)-
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guided needle prior to any operative procedure on the
breast or axilla, regardless of whether the nodes
appeared normal or abnormal.
Lymph node classification
Lymph nodes were classified into four categories accord-
ing to criteria derived from Stavros’ classification: normal
“N”, minimally suspect “+”, mildly suspect “++” and
highly suspect “+++”. The details of these classifications
are as follows:
– “+”: lymph node with a maximum size of cortical
thickness of 3 mm with regular capsular thickening
– “++”: lymph node with irregular capsular thickening
(with notches) or with regular capsular thickening
and cortical thickness greater than 3 mm in size
– “+++”: complete loss of lymph node structure;
irregular cortex or absence of lymph node hilum.
Normal or “+” lymph nodes were considered non-
suspicious, and “++” and “+++” lymph nodes were
considered suspicious (Fig. 1).
Cytoblock and cytospin techniques
The sample obtained by US-guided fine-needle aspir-
ation (USG-FNA) was placed in Saccomanno fluid and
sent to the laboratory where it was separated into two
samples: one for the CB technique and one for the
cytospin technique. Both samples were centrifuged at
1400 rpm for 10 min. The cytospin sample was placed
in a Shandon EZ Cytofunnel® with a few drops of
concentration solution, then placed in the Shandon
Cytospin®4 centrifuge for 10 min at 500 rpm. It was then
placed on a microscope slide for cytologic analysis. For
CB, 2–4 drops of Reagent 2 from the cytoblock kit were
added to the pellet, and it was resuspended and incu-
bated for one minute. Two to four drops of Reagent 1
from the kit were added, causing polymerization. After
one minute, the resulting polymerized material was
placed between two sponges in a standard cassette and
routinely processed with other biopsies and paraffin-
embedded blocks. Four-micron sections were cut and
stained with hematoxylin and eosin. Immunohistochem-
istry (IHC) was performed on each cytoblock using
broad-spectrum cytokeratin primary antibodies (clone
AE1-AE3, dilution: 1/100, Dakocytomation, Glostrup,
Denmark).
The CB results were classified into one of three cat-
egories: “C1” inadequate, “C2” negative and “C5”
malignant.
Histological assessment
From the 208 CBs, only 93 had final histological
confirmation of axillary lymph nodes after axillary lymph
node dissection or sentinel node biopsy. These were cat-
egorized as either negative, when all of the examined
lymph nodes were negative for metastasis, or positive,
when there was evidence of metastasis in one or
more lymph nodes. The same histopathologist per-
formed histological assessments. Of the 93 results,
only 54 had no neoadjuvant chemotherapy and were
thus interpretable (Fig. 2).
The results were analyzed according to the type of
breast cancer, the size of the evaluated lymph nodes,
type of surgery (sentinel node biopsy or axillary lymph
node dissection), surgeon, radiologist, patient’s age,
patient’s BMI, and the presence or absence of neoadju-
vant chemotherapy.
Results
Ninety-three CBs from 80 patients who underwent sur-
gery had histological confirmation of axillary lymph nodes
after sentinel node biopsy or axillary lymph node dissec-
tion. The 80 patients were between 28 and 84 years old.
Tumor size was between 4 and 85 mm, and the axillary
lymph node size was between 5 and 42 mm. In 73 cases,
an axillary lymph node dissection was performed, and in
20 cases a sentinel node biopsy was performed.
Because 39 patients received neoadjuvant chemother-
apy, the histological results from their surgeries were
not interpretable. In effect, only the 54 patients who
did not receive neoadjuvant chemotherapy were ana-
lyzed. Among these, 15 had non-suspicious lymph
nodes (N), 23 were minimally suspect, nine were mildly
suspect, and seven were highly suspect (Table 1). Five
CBs were inadequate, 39 were negative, and 10 were
positive (Table 2).
Of the 54 cases without neoadjuvant chemotherapy,
34 had a negative histological result and 20 had a
positive histological result. Of the 34 negative results, 14
had an echo of N, 18 echo of + (also considered non-
suspicious) and only two had an echo of ++. Of the 20
positive results, one had an echo N, five had + echoes,
seven had ++ echoes, and seven had +++ echoes.
Of the 54 cases without neoadjuvant chemotherapy,
34 had a negative histological result and 20 had a posi-
tive histological result. Of the 34 negative results, only 2
had non-contributory CB (C1), 32 had negative CB (C2)
and there were no positive CB (C5). Of the 20 positive
results, 3 had non-contributory CB (C1), 7 had negative
CB (C2) and 10 had positive CB (C5).
The final histological result was negative for 34 cases
and positive for 20 cases.
Of the 38 non-suspicious lymph nodes based on US
(N or “+”) in patients who did not have neoadjuvant
therapy, lymph node metastasis was found in six cases
(15.8 %), whereas there were no malignant cells in 32
cases (84.2 %) (Table 1).
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Of the 16 suspicious lymph nodes based on US (“++”
or “+++”) in patients who did not receive neoadjuvant
therapy, lymph node metastasis was found in 14 cases
(87.5 %), and no malignant cells were detected in two
cases (12.5 %) (Table 1).
All metastatic axillary lymph nodes identified by CB
preparation in the absence of neoadjuvant chemotherapy
(C5) had positive final histological results (100 %)
(Table 2).
Of the 39 axillary lymph nodes in which metastasis
was not found by CB preparation (C2), 32 had negative
final histological results in the absence of neoadjuvant
chemotherapy (82 %), and seven had positive final
histological results (18 %) (Table 2).
Fig. 1 Sonographic images of a minimally suspect axillary lymph node “+” (A), a mildly suspect axillary lymph node “++” (B) and highly suspect
axillary lymph node “+++” (C)
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The results of the pre-operative lymph node staging by
US and by CB preparation with the final histological
result were compared using a χ2 statistical test. A statis-
tically significant correlation was found between the
results in the two cases (Table 2). The results obtained
were statistically significant (χ2 23.691 (p = 0.00000717)
for CB and χ2 25.381 (p = 0.00000046) for US.
Of the C5 lymph nodes (10 cases) or those found by
US to be suspicious (9 “++” and 7 “+++”) in the pre-
operative evaluations (26 cases), only two cases of “++”
were ultimately negative in the absence of neoadjuvant
therapy in the final histological results.
To determine whether some of the variables could
explain a discordance in the results, or whether the rate
of contribution changed depending on these variables,
the impact of the variables on the results were analyzed
using a χ2 statistical test. None of the variables were
found to be statistically significant.
In comparing the results of the CB preparation to
those of the cytospins (57 cases), only three cases were
discordant: three cases of inadequate CB had cytospin
results of C3, C4 or C5.
A comparison of axillary lymph node status between
CB preparation or US, and the final histological results
of lymph nodes after surgery in the absence of neoad-
juvant chemotherapy, indicated that false-negative re-
sults for metastasis were identified by CB in seven cases
(7/39, 18 %) compared to one “N” (1/15, 6.67 %) and five
“+++” (5/23, 21.7 %) cases obtained by US alone (6/38,
15.8 %). Moreover, the CB technique showed 0 % false-
positive cases compared to 12.5 % (two “++”, 16 “++”,
and “+++”) false-positive cases obtained by US alone.
The results summarized in Table 3 show the sensitivities,
specificities, positive predictive values (PPV) and nega-
tive predictive values (NPV) for US alone compared to
CB, excluding CB cases with inadequate results, and
patients who received neoadjuvant chemotherapy.
Fig. 2 Two hundred and eight cytoblocks (CB) were performed at Erasme Hospital between October 2008 and August 2012. Of these, 93 cases
had sonography, cytoblock and axillary surgery. Of the CBs performed, 37 were positive and 56 were negative or non-contributory (NC). Of the 37
positive CB, 10 did not receive neoadjuvant therapy. Of the 56 negative or NC cytoblocks, 44 did not receive neoadjuvant chemotherapy
Table 1 Lymph nodes histological results according to
pre-operative sonographic results
Histological results from surgery
Echography Negative (%) Positive (%) Total
Echo N 14 (93) 1 (7) 15 (100)
Echo + 18 (78) 5 (22) 23 (100)
Echo ++ 2 (22) 7 (78) 9 (100)
Echo +++ 0 7 (100) 7 (100)
Total 34 (63) 20 (27) 54 (100)
Table 2 Lymph nodes histological results according to
pre-operative cytoblock results
Histological results from surgery
Cytoblock Negative (%) Positive (%) Total
C 1 2 (40) 3 (60) 5 (100)
C 2 32 (82) 7 (18) 39 (100)
C 5 0 10 (100) 10 (100)
Total 34 (63) 20 (37) 54 (100)
De Coninck et al. BMC Medical Imaging  (2016) 16:13 Page 4 of 6
Based on the values displayed in Tables 1 and 2, we
calculated the sensitivity, specificity, positive predictive
value (PPV) and negative predictive value (NPV) of
echography* and cytoblock both alone and together.
*Echoes of N and + were considered non-suspicious;
echoes of ++ and +++ considered suspicious.
For the “++” and “+++” lymph nodes classified as
suspicious in the absence of neoadjuvant therapy, the
sensitivity of CB in the 54 cases was 58.8 % compared to
68.4 % for US. The specificity (100 % versus 94.1 %),
PPV (100 % versus 86.7 %) and NPV (82.1 % versus
84 %) values were high for both diagnostic methods
(Table 3).
In cases where only the “+++” lymph nodes were
considered suspicious, the sensitivity of CB in the 54
cases was 58.8 % compared to 85.7 % for US. Specificity
was 100 % versus 100 %, PPV was 100 % versus 100 %,
and NPV was 82.1 % versus 93.3 % (Table 3).
For non-suspicious lymph nodes with N or “+” results
from US and C2 (a combination of the CB and US
techniques) without neoadjuvant therapy, the sensitivity
was 75 %, specificity was 94.1 %, PPV was 88.2 % and
NPV was 86 % (Table 3).
These results support the hypothesis that pre-operative
CB from USG-FNA biopsy of axillary lymph nodes, and
axillary US using a modified version of Stavros’ classifica-
tion, are two promising methods of pre-operative axillary
staging, with axillary US being the preferred means
of staging.
Discussion
This study is based on a series of CBs from USG-FNA
and sonography of axillary lymph nodes in patients with
primary invasive breast cancer. Among non-invasive
approaches, US and USG-FNA cytology have been re-
ported to have high accuracy for staging axillary lymph
nodes. Published estimates of USG-FNA cytology show a
sensitivity varying from 25 to 87 %, a specificity ranging
from 14 to 100 %, an NPV between 54 and 78 % and a
PPV ranging from 37 to 100 % [6, 7, 9–13]. The results
obtained in our study are similar to and even exceed these
published findings. The only study to have previously
described results from the CB technique, Engohan et al.,
has results very similar to those described here, with a
better sensitivity (73 % versus 58 %), a lower NPV (78 %
versus 82 %) and same specificity and PPV (100 %).
Analysis of our results showed that for patients with posi-
tive nodes by CB (C5) or positive nodes by US (“+++”),
the probability of having axillary nodal metastasis upon
surgery in the absence of neoadjuvant therapy is 100 %
(PPV). Similarly, for patients with negative nodes by the
CB technique and by US (N or “+”), the probability of
having no axillary nodal metastasis upon surgery is 86.5 %
(NPV) in the absence of neoadjuvant chemotherapy.
We found seven false-negative cases by the CB tech-
nique and by US, including one that had an inadequate
CB result. Another false-negative lymph node was evalu-
ated simultaneously with an ipsilateral lymph node that
was positive at pre-operative staging; surgery showed
two positive lymph nodes out of 12 analyzed. In effect,
the second node was confirmed as positive without
insurance, because the pathologist could not prove
which one was the one diagnosed before surgery. We
also found two false-positive cases by US when the CB
result was negative, and the size of the pre-operative
lymph node, as determined by US, was not the same as
that measured by the pathologist after surgery.
This analysis reveals some limitations to our study.
First, it is possible that the lymph node analyzed by
the pathologist after surgery (sentinel node biopsy or
axillary lymph node dissection) was not the same one
as that evaluated by US and USG-FNA during pre-
operative staging.
Additionally, there were 39 cases of lymph nodes from
patients who had received neodajuvant chemotherapy.
For those cases, it is not possible to compare the pre-
operative and final histological results.
Conclusion
Axillary lymph node status is an important component
of staging and treatment planning in breast cancer. Our
study confirms that the use of a combination of US and
CB may improve the evaluation of axillary lymph nodes
in patients with primary breast cancer. These techniques
are simple, inexpensive, minimally invasive, and allow
for immunostaining. They also permit the referral of
patients with primary breast cancer to neoadjuvant
chemotherapy if the CB result is C5 or if the US result is
“+++”. In the same way, for patients with a CB result of
C2 and US result N or “+”, these techniques may pre-
clude the use of neoadjuvant chemotherapy. Given the
limited number of cases in our study, additional, new
studies will be necessary.
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Echography* 68.4 94.1 86.7 84
Cytoblock 58.8 100 100 82.1
Echography* +
Cytoblock
75.0 94.1 88.2 86.5
* Echography N and + considered as non suspicious; echography ++ and +++
considered as suspicious
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